

Cover Story
Capitol Hill
Amid the flood zone of today’s Washington, the confirmation hearing for Jayanta (Jay) Bhattacharya’s nomination as director of NIH was remarkably calm.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for March 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - Bhattacharya: New grant review criterion is “not political”
- With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shut down
- Population-based cancer surveillance is a national treasure at risk
- Ci4CC’s 24th Symposium & Workshop set to focus on precision oncology powered by data intelligence